Home
>
National Drug Code (NDC)
>
Belviq
Belviq - 62856-529-60 - (lorcaserin hydrochloride)
Drug Information of Belviq
| Product NDC: | 62856-529 |
| Proprietary Name: | Belviq |
| Non Proprietary Name: | lorcaserin hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; lorcaserin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Belviq
| Product NDC: | 62856-529 |
| Labeler Name: | Eisai, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022529 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120627 |
Package Information of Belviq
| Package NDC: | 62856-529-60 |
| Package Description: | 60 TABLET in 1 BOTTLE (62856-529-60) |
NDC Information of Belviq
| NDC Code | 62856-529-60 |
| Proprietary Name | Belviq |
| Package Description | 60 TABLET in 1 BOTTLE (62856-529-60) |
| Product NDC | 62856-529 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lorcaserin hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120627 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai, Inc |
| Substance Name | LORCASERIN HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin-2c Receptor Agonist [EPC],Serotonin 2c Receptor Agonists [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
